Funds Advised by Permira Acquire Neuraxpharm from Funds Advised by Apax Partners

September 22, 2020

Funds advised by Permira have agreed to acquire the controlling stake in Neuraxpharm, a leading European specialty pharmaceuticals company focused on central nervous system (CNS) disorders, from funds advised by Apax Partners. Financial terms were not disclosed; Neuraxpharm had annual revenues in excess of €460 million and around 850 employees under Apax's ownership.

Buyers
Funds advised by Permira
Targets
Neuraxpharm
Sellers
Funds advised by Apax Partners
Industry
Pharmaceuticals
Location
Spain
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.